How to Obtain Wegovy: the Legal UK Route Explained

You've searched, you've read the headlines, here's where most people get stuck

Most people arrive at this question after a similar journey. They've seen Wegovy discussed in the press, heard from someone who's been on it, maybe looked at their own BMI and thought it might be worth exploring. Then they hit a wall: NHS waiting lists measured in months or years, GP practices that aren't yet prescribing it, and a chaotic online market where prices and promises vary wildly. It's a reasonable place to feel confused.

Let's be direct. Wegovy is a prescription medicine, no legitimate route exists outside a clinical assessment. The assessment isn't a formality, either. A prescriber checks your current medications, your medical history, blood pressure, and whether the licensed BMI threshold applies to you. For some ethnic backgrounds, UK clinical guidance sets the qualifying BMI 2.5 kg/m² lower than the standard thresholds. The prescriber also needs to know about any contraindications: a personal or family history of medullary thyroid carcinoma, for example, rules it out.

Understanding what Wegovy contains helps here. Semaglutide works on GLP-1 receptors involved in appetite regulation and gastric emptying, which is why the clinical assessment covers your GI history as well as your weight. The prescriber isn't being obstructive; they're matching the treatment to the individual.

If the assessment is clear, Wegovy can be prescribed. What happens next depends on whether you're going through the NHS or a private pharmacy.

The NHS route: what the criteria actually look like in 2025 and 2026

NICE recommended Wegovy (semaglutide for weight management) under Technology Appraisal TA875, but the NHS conditions attached to that recommendation are specific. On the NHS, Wegovy is available only through specialist weight management services, not a standard GP appointment, and for a maximum of two years. You generally need a BMI of 35 or above plus at least one weight-related comorbidity, though that threshold is lower for some ethnic backgrounds.

NHS England has been phasing in tirzepatide (Mounjaro) through GP practices since mid-2025, with strict cohort criteria. Wegovy through the NHS remains routed primarily through specialist services, and waiting lists at those services are commonly long. Scotland, Wales and Northern Ireland have their own access pathways, and criteria differ between them.

If you do qualify and can access the NHS route, Wegovy comes as part of a structured programme including diet and activity support, and your prescriber will review your progress, the guidance recommends stopping if you haven't lost at least 5% of body weight after six months on your maintenance dose. If you're approaching that point or thinking ahead, the guidance on how to stop Wegovy explains what to expect when the treatment ends and how to manage the transition.

For many people, the NHS route is either out of reach on eligibility grounds or the wait is too long. That's where private prescribing comes in, and it's a legitimate option, provided the pharmacy is properly regulated. Take thirty seconds to search the GPhC pharmacy register before handing over any personal details to an online provider. That single check separates regulated services from unregistered ones.

Obtaining Wegovy through a private regulated pharmacy

A regulated private service follows exactly the same clinical framework as the NHS version, a real prescriber, a genuine assessment, a prescription, and a licensed supply chain. What changes is the speed and the eligibility window. Privately, you don't need to be in a specialist service or wait for an NHS cohort to open. The licensed eligibility criteria apply: BMI 30 or above, or 27 or above with a qualifying condition.

At nume, every consultation is personally reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reads your answers, not software. Identity is verified with photo ID, and weight is confirmed on a live video call. If you're approved and order before noon on a working day, your treatment is dispatched the same day and arrives free the next working day via DPD in plain packaging.

One transparent price covers the consultation, prescription, medicine and delivery. There are no subscription commitments and no auto-renewals. Before every repeat order, a prescriber re-reviews your case. For a more detailed look at how the semaglutide treatment journey typically unfolds, the guide to starting Wegovy covers the first weeks in practical terms.

The cost of private treatment is worth understanding before you commit. For context on what the UK private market typically charges and what to look for in a quoted price, the Wegovy cost and access page breaks this down honestly.

Red flags to avoid when searching online

The MHRA has been explicit about the risks of obtaining these medicines from unverified sources. Counterfeit weight-loss pens have been seized in large quantities across the UK, and some fake products have contained insulin rather than semaglutide, a potentially life-threatening substitution. In October 2025, enforcement raids found illicit manufacturing of counterfeit tirzepatide pens operating inside the UK.

The warning signs are consistent: sellers offering Wegovy without asking you to complete any clinical assessment, social media accounts advertising far-below-market prices, and "discount codes" for prescription medicines from sources you can't verify. Legitimate providers don't offer discount codes for POMs. Report any suspect sellers through the MHRA Yellow Card scheme, which accepts reports about both suspected side effects and suspect products.

The semaglutide overview covers the broader clinical picture if you want more background before booking a consultation. When you're ready to check whether you're eligible, the free consultation takes a few minutes and is reviewed the same day.